Urgent Need to Increase Respiratory Virus Immunization Coverage
Vaccine coverage is low for all recommended respiratory vaccines. Continue to recommend and administer influenza, COVID-19, and RSV immunizations to prevent severe illness.
Also remember to treat COVID-19 and influenza – antiviral medications are important but underutilized.
Refer to this CDC Health Alert for more information. Refrigerated Pfizer 12y+ COVID-19 Vaccine Coming Next Week
CDC will be replacing the current Pfizer COVID-19 vaccine for persons 12y+ (NDC 00069-2362-10) on CDC’s pediatric and adult contracts with this new presentation: - NDC 00069-2377-10 refrigerated formulation (product has never been frozen)
- The carton will contain 10 prefilled syringes
- Must be stored refrigerated between 2°C and 8°C (36°F and 46°F)
- Shelf life aligns with the expiration date printed on the carton and syringe labels (6 months from production to expiry)
Of note: Pfizer will continue to allow providers to privately order the original manufacturer-filled syringes (MFS) for age 12+. Therefore, providers may have BOTH presentations – MFS with a 10-week Beyond Use Date (BUD) and MFS that can be used through the expiration date - in their storage units. If this occurs, providers should educate staff on the different storage requirements and strategies to prevent potential errors.
For more information and resources, refer to this CDPH message.
Update: Sunsetting the U.S. Government COVID-19 Therapeutics Distribution Program
Paxlovid Ordering: As of December 15, 2023, 3PM ET, ordering for HHS-distributed Paxlovid is closed except for federal entities. Please use your traditional commercial ordering mechanisms to order commercially available Paxlovid. Providers with excess USG-distributed, EUA-labeled Paxlovid with an expiration date of December 2023 or later are encouraged to return product through the Pfizer returns process by December 31. Lagevrio Ordering: As of December 15, 2023, 3PM ET, ordering for HHS-distributed Lagevrio closed for all entities. Please use your traditional commercial ordering mechanisms to order commercially available Lagevrio. USG-procured Lagevrio should be used until depleted or expired, whichever comes first. For more information, please see: COVID-19 Therapeutics Commercialization Transition Guide (hhs.gov) Summary of COVID-19 Preventative Agents and Treatments
Upcoming Webinar Cancellations and Closures
- The CDPH Immunization Updates for Providers are cancelled on the following dates:
- Friday, December 22, 2023
- Friday, December 29, 2023
- The Provider Call Center will be closed on Monday, December 25, 2023, and Monday, January 1, 2024.
Holiday Ordering Cadence
For information on ordering cadence changes see the following calendars:
The My Turn and myCAvax Teams Appreciate Your Feedback! Please use the Vaccine Management Feedback Form to provide feedback and suggestions for the My Turn and myCAvax platforms. Support Opportunities
CDPH Immunization Branch Updates for Providers Please attend our weekly webinars to hear updates from CDPH subject matter experts and have your questions answered.
Next session: Friday, January 5, 2024 Fridays 9:00AM – 10:30 AM Archived Sessions | Provider FAQs Provider Call Center For Program information: email providercallcenter@cdph.ca.gov or call (833) 502-1245 (Monday – Friday, 8AM–5PM) myCAvax Help Desk For technical issues (password resets, etc.): email myCAvax.HD@cdph.ca.gov or call (833) 502-1245, (Monday – Friday, 8AM – 5PM PT) System related training materials are available via the Knowledge Center in myCAvax and at EZIZ.org. My Turn Help Desk |
